BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35962317)

  • 1. Machine learning for the micropeptide encoded by LINC02381 regulates ferroptosis through the glucose transporter SLC2A10 in glioblastoma.
    Jiang L; Yang J; Xu Q; Lv K; Cao Y
    BMC Cancer; 2022 Aug; 22(1):882. PubMed ID: 35962317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion.
    Huan R; Zhang J; Yue J; Yang S; Han G; Cheng Y; Tan Y
    J Cell Mol Med; 2024 May; 28(9):e18318. PubMed ID: 38685674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
    Zheng XJ; Chen WL; Yi J; Li W; Liu JY; Fu WQ; Ren LW; Li S; Ge BB; Yang YH; Zhang YZ; Yang H; Du GH; Wang Y; Wang JH
    Acta Pharmacol Sin; 2022 Nov; 43(11):2977-2992. PubMed ID: 35581292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
    Le Calvé B; Rynkowski M; Le Mercier M; Bruyère C; Lonez C; Gras T; Haibe-Kains B; Bontempi G; Decaestecker C; Ruysschaert JM; Kiss R; Lefranc F
    Neoplasia; 2010 Sep; 12(9):727-39. PubMed ID: 20824049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
    Deng S; Zheng Y; Mo Y; Xu X; Li Y; Zhang Y; Liu J; Chen J; Tian Y; Ke Y
    World Neurosurg; 2021 Aug; 152():e436-e448. PubMed ID: 34062295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
    Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
    Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.
    Wang J; Li T; Wang B
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma.
    Cirotti C; Taddei I; Contadini C; Di Girolamo C; Pepe G; De Bardi M; Borsellino G; Helmer-Citterich M; Barilà D
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37879937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
    Chai Y; Wang C; Liu W; Fan Y; Zhang Y
    J Neurooncol; 2019 Sep; 144(2):293-301. PubMed ID: 31236818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
    Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
    J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
    Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
    Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
    Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
    Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of Nrf2 modulators for the treatment of glioblastoma multiforme.
    Yang H; Song P; Li B; Li S; Yang J
    Bioorg Med Chem; 2024 Apr; 103():117684. PubMed ID: 38493731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
    Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
    Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.